[1]
Van Doorn P. A., Ruts L., Jacobs B. C. : Clinical features, pathogenesis,
and treatment of Guillain-Barré syndrome. Lancet Neurol 2008; 7: 939–
950.
[2]
Jóźwiak S.: Zespół Guillaina-Barrégo u dzieci. [w:] Postępy w diagnostyce
i leczeniu chorób układu nerwowego u dzieci. T. 3, oprac. zbiorowe pod
red. Jóźwiak S. Bifolium, Lublin 2001.
[3]
Lipowska M., Opuchlik A.: Standardy diagnostyki i leczenia zespołu
Guillaina-Barrégo. Neurologia po Dyplomie, Zeszyt Edukacyjny Wrzesień
2011 – Standardy diagnostyki i leczenia chorób demielinizacyjnozapalnych
układu nerwowego.
[4]
Kostera-Pruszczyk A., Potulska-Chromik A.: Zasady diagnostyki
elektrofizjologicznej zespołu Guillaina-Barrégo i przewlekłej zapalnej
polineuropatii demielinizacyjnej. Neurologia po Dyplomie, Zeszyt
Edukacyjny Wrzesień 2011 – Standardy diagnostyki i leczenia chorób
demielinizacyjno-zapalnych układu nerwowego.
[5]
Tam C. C., O’Brien S. J., Petersen I., et al.: Guillain-Barré syndrome
and preceding infection with Campylobacter, influenza and Epstein-
Barr virus in the General Practice Research Database. [6 screen pages]
Address: http://journals.plos.org/plosone/article?id=10.1371/journal.
pone.0000344.
[6]
Stowe J., Andrews N., Wise L., et al.: Investigation of the temporal
associationof Guillain-Barré syndrome with influenza vaccine and
influenza like illness using the United Kingdom General Practice Research
Database. Am J Epidemiol 2009; 169(3): 382–8. [7 screen pages]
Address: http://aje.oxfordjournals.org/content/169/3/382.long.
[7]
Sejvar J. J., Baughman A. L., Wise M., et al.: Population incidence
of Guillain-Barré syndrome: a systematic review and meta-analysis.
Neuroepidemiology 2011; 36(2): 123–133.
[8]
Hughes R. A., Swan A. V., Van Doorn P.A.: Intravenous immunoglobulin
for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2014 Sep
19; 9. [67 screen pages] Address: http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD002063.pub6/full.
[9]
Winer J. B.: An Update in Guillain-Barré syndrome. Autoimmune Dis
2014; 2014: 793024 [6 screen pages] Address: http://www.ncbi.nlm.
nih.gov/pmc/articles/PMC3910670/.
[10]
Kopyta I., Wardak S.: Przypadek izolacji pałeczek Campylobacter Jejuni
od pacjenta z zespołem Guillaina-Barrégo. Med. Dośw. Mikrobiol. 2008,
60: 59–63.
[11]
Tatarelli P., Garnero M., Bono V. D., et al.: Guillain-Barré syndrome
following chickenpox: a case series. Int J of Neurosci series. [5 screen
pages] Address: http://www.tandfonline.com/doi/pdf/10.3109/0020745
4.2015.1033621.
[12]
ECDC: Guidance Varicella vaccination in the European Union.
Address: http://ecdc.europa.eu/en/publications/Publications/Varicella-
Guidance-2015.
[13]
Liu J., Wang L. N., McNicol E. D.: Pharmacological treatment for pain
in Guillain-Barré syndrome. Cochrane Neuromuscular Disease Group
2015; Apr. [34 screen pages] Address: http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD009950.pub2/epdf.
[14]
Bhargava A. , Banakar B. F. , Pujar G. S., et al.: A study of Guillain-
Barré syndrome with reference to cranial neuropathy and its prognostic
implication. J Neurosci Rural Pract 2014 Nov; 5 (Suppl 1): S43–S47.
[5 screen pages] Address: http://www.ncbi.nlm.nih.gov/pmc/articles/
PMC4271381/.
[15]
Varkal M. A.. , Uzunhan T. A. , Aydınli N., et al.: Pediatric Guillain-Barré
syndrome: Indicators for a severe course. Ann Indian Acad Neurol 2015
Jan–Mar; 18(1): 24–28. [5 screen pages] Address: http://www.ncbi.
nlm.nih.gov/pmc/articles/PMC4350209/.
[16]
Wu X., et al.: Critical Care 2015, 19: 310. [9 screen pages] Address:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557605/.
[17]
Ravishankar N.: Respiratory paralysis in a child: The severe axonal
variant of childhood Guillain-Barré syndrome. J Pediatr Neurosci 2015
Jan-Mar; 10(1): 67–69. [3 screen pages] Address: http://www.ncbi.nlm.
nih.gov/pmc/articles/PMC4395953/.
[18]
Tekgul H., et al.: Outcome of Axonal and Demyelinating Forms of Guillain-
Barre´ Syndrome in Children. Pediatr Neurology 2003; 28(4): 295–299.
[5 screen pages].
[19]
Kuitwaard K., De Gelder J., Tio-Gillen A. P., et al.: Pharmacokinetics of
intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
Annals of Neurology 2009; 66(5): 597–603.
[20]
Bradshaw D. Y., Jones H. R.: Guillain-Barre syndrome in children: clinical
course, electrodiagnosis, and prognosis. Muscle Nerve 1992; 15: 500–
506.
Scholar Google
PubMed